EXTON, PA — ProRx Pharma has announced the launch of its new Liquid Nanoemulsion Delivery System — a patented, needle-free alternative to traditional injectable medications. The innovation positions ProRx as the only 503B facility in the United States with exclusive rights to this advanced delivery technology.
The system uses nanoemulsion science to encapsulate medication in lipid-based particles so small they can be rapidly absorbed through the tissues of the mouth, either under the tongue or inside the cheek. This process allows drugs to enter the bloodstream directly, bypassing the digestive system for faster, more efficient absorption.
“Healthcare providers are increasingly seeking fast-acting therapies that deliver both reliability and convenience,” said Kurt Lunkwitz, chief operating officer at ProRx. “Our new Liquid Nanoemulsion Delivery System allows ProRx to offer customized formulations from the Bulk Drug Substances list for providers who are looking to minimize injections for their patients without compromising results. Our investment in this technology underscores our commitment to safety, science, and innovation—giving clinicians a new option for patients who choose or need non-injectable therapies.”
The delivery platform’s key advantages include improved bioavailability, no refrigeration requirements, and consistent absorption rates. By eliminating the need for injections, ProRx aims to enhance compliance among patients who prefer non-invasive treatment options.
The initial product lineup for the system includes Sermorelin, NAD+ (Nicotinamide Adenine Dinucleotide), and Testosterone, each available in 1mL daily ampules. All formulations are compounded in ProRx’s DEA-registered 503B facility under stringent U.S. Pharmacopeia (USP) <797> and Current Good Manufacturing Practices (cGMP) standards, with every batch undergoing third-party potency, purity, and sterility testing.
“In my medical practice, we see patients — who have been on injectables for years — excited about these oral therapies,” said Dr. Cindy Zughbi, medical director at Vitality Health of South Florida. “Previously, the therapeutic effect of other oral and topical testosterone has been very low. I’m happy to be able to provide a service for our patients where they’re able to maintain consistent testosterone levels with a high therapeutic effect without having to use injections.”
With its Liquid Nanoemulsion Delivery System, ProRx is expanding access to precision therapies that combine scientific rigor with patient convenience — offering a new frontier in personalized medicine and preventative health care.
For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.